Premium
Transvaginal mesh, gender and the ethics of clinical innovation
Author(s) -
Wiersma Miriam,
Kerridge Ian,
Lipworth Wendy
Publication year - 2020
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.14833
Subject(s) - medicine , vulnerability (computing) , harm , surgical mesh , do no harm , general surgery , nursing , law , psychiatry , computer security , computer science , political science , hernia
Abstract On 10 October 2018, Australian Health Minister Greg Hunt issued a national apology to the Australian women who experienced ‘horrific outcomes’ following surgery using transvaginal mesh—acknowledging the ‘historic agony and pain that has come from mesh implantation’. This apology followed many decades of ‘innovative’ use of transvaginal mesh for the treatment of pelvic organ prolapse. We use the case of transvaginal mesh to explore how clinical innovation may not only harm patients, but also entrench vulnerability and exacerbate existing inequities—in this case, those relating to gender.